Back to today’s briefing

Story perspectives

GLP-1 Drugs Boost Sleep, Cut Grocery Costs for Diabetics

1/5/2026

32 5 Full Breakdown

Summary

Story summary

A study published in JAMA Network Open finds glucagon-like peptide-1 (GLP-1) weight-loss drugs Ozempic and Zepbound may improve sleep apnea in obese patients with type 2 diabetes.
Patients using drugs were 8% less likely to require CPAP.
They were 32% less likely to die from any cause.
Study shows households with GLP-1 drug users cut grocery spending by 5%, about $390, on less-healthy foods.
Stopping medication may reverse spending patterns.

1 of 1

Story summary

A study published in JAMA Network Open finds glucagon-like peptide-1 (GLP-1) weight-loss drugs Ozempic and Zepbound may improve sleep apnea in obese patients with type 2 diabetes.
Patients using drugs were 8% less likely to require CPAP.
They were 32% less likely to die from any cause.
Study shows households with GLP-1 drug users cut grocery spending by 5%, about $390, on less-healthy foods.
Stopping medication may reverse spending patterns.